NMO SPECTRUM DISORDER

Clinical trials for NMO SPECTRUM DISORDER explained in plain language.

Never miss a new study

Get alerted when new NMO SPECTRUM DISORDER trials appear

Sign up with your email to follow new studies for NMO SPECTRUM DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1

CAR-T therapy for autoimmune diseases: trial pulled before start

Disease control Terminated

This early-phase trial aimed to test a CD19-targeted CAR-T cell therapy (RD06-04) in people with autoimmune diseases like lupus, multiple sclerosis, and myasthenia gravis. The goal was to see if the treatment was safe and could reduce disease activity. However, the study was with…

Matched conditions: NMO SPECTRUM DISORDER

Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control

Last updated May 04, 2026 16:20 UTC

NMO SPECTRUM DISORDER

Get alerted when new NMO SPECTRUM DISORDER trials appear

CAR-T therapy for autoimmune diseases: trial pulled before start